Mboglen Diane: Why ATLS 11 Places Hemorrhage Control Before Airway Management
Mboglen Diane, Executive Assistant to Chief Executive Officer at Pro Career Builder, Medical Doctor at Vision Health Clinic, shared a post on LinkedIn:
“Massive bleeding kills faster than airway compromise.
That single reality has led to one of the most important updates in trauma care in recent years.
For decades, healthcare professionals have been taught the ATLS primary survey:
- Airway
- Breathing
- Circulation
- Disability
- Exposure
With the release of ATLS 11, the sequence has evolved to: ABCDE
The ‘X’ represents exsanguinating (catastrophic) hemorrhage—severe bleeding that must be identified and controlled immediately, even before airway assessment.
Why?
Because a patient can lose a critical volume of blood and die within minutes.
If catastrophic bleeding is not stopped, securing the perfect airway may not change the outcome.
This update reflects growing evidence from civilian and military trauma care showing that rapid hemorrhage control saves lives.
The priority is now clear:
- Control catastrophic bleeding
- Apply direct pressure, tourniquets, or hemostatic dressings when indicated
- Then proceed with Airway, Breathing, Circulation, Disability, and Exposure
ATLS 11 is a reminder that medicine continuously evolves with evidence.
As healthcare professionals, staying current with these changes helps us provide safer, more effective care when seconds matter most.
What are your thoughts on the shift from ABCDE to xABCDE?
Have you already incorporated this approach into your trauma practice?”

Stay updated with Hemostasis Today.
-
Jul 20, 2026, 09:41Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026
-
Jul 20, 2026, 08:58Samantha Pasca: Insights into Pain and Coping in Hemophilia at ISTH 2026
-
Jul 20, 2026, 08:08Ifeanyichukwu Ifechidere: COVID-19 Changed Our Understanding of Coagulation
-
Jul 20, 2026, 07:27Vonwicks Czelestakov Onyango: The Anticoagulation Dilemma in Ulcerative Colitis
-
Jul 20, 2026, 06:14Elen Avetisyan: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026